Feifei Kong
Impact in
- Aging top 10%
- Genetics, Aging, and Longevity in Model Organisms
- Reproductive Medicine top 10%
- Ovarian function and disorders
- Sperm and Testicular Function
Papers in
-
- FOXO transcription factor regulation 2
- Oncology 6
- Cancer Cells and Metastasis 3
- Co-authors
- Jing Li (5 shared papers)Jing Zhang (3 shared papers)Wenwen Liu (3 shared papers)Xiaoxu Peng (3 shared papers)Xiaowei Dou (3 shared papers)Haihua Yuan (2 shared papers)Sun Yan (1 shared paper)Bin Jiang (2 shared papers)
- Journals
- Cell Death and Disease (3 papers)Autophagy (1 paper)British Journal of Cancer (1 paper)Oncology Reports (1 paper)Journal of Cellular Physiology (1 paper)
- Partner nations
- China
In The Last Decade
Feifei Kong
17 papers receiving 344 citations
Peers
Comparison fields: 5 of 63
- Aging 33
- Reproductive Medicine 68
- Cancer Research 57
- Public Health, Environmental and Occupational Health 101
- Molecular Biology 172
Countries citing papers authored by Feifei Kong
This map shows the geographic impact of Feifei Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feifei Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feifei Kong more than expected).
Fields of papers citing papers by Feifei Kong
This network shows the impact of papers produced by Feifei Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feifei Kong. The network helps show where Feifei Kong may publish in the future.
Co-authors
The 25 scholars most cited alongside Feifei Kong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 104 | |
| 2 | 2014 | 75 | |
| 3 | 2016 | 32 | |
| 4 | 2014 | 27 | |
| 5 | 2017 | 25 | |
| 6 | 2023 | 15 | |
| 7 | 2014 | 15 | |
| 8 | 2017 | 10 | |
| 9 | 2021 | 9 | |
| 10 | 2023 | 9 | |
| 11 | 2017 | 7 | |
| 12 | 2024 | 6 | |
| 13 | [TNF-α activates Wnt signaling pathway to promote the invasion of human colon cancer stem cells]. | 2018 | 6 |
| 14 | 2024 | 2 | |
| 15 | 2025 | 2 | |
| 16 | 2022 | 2 | |
| 17 | 2024 | 1 | |
| 18 | 2025 | 0 | |
| 19 | Efficacy of everolimus combined with endocrine therapy in HR-positive/HER-2-negativeadvanced breast cancer. | 2021 | 0 |
About Feifei Kong
Feifei Kong is a scholar working on Molecular Biology, Oncology, Public Health, Environmental and Occupational Health, Reproductive Medicine and Cancer Research, having authored 19 papers that have together received 347 indexed citations. Recurring topics across this work include Reproductive Biology and Fertility (4 papers), Cancer Cells and Metastasis (3 papers), Cancer, Lipids, and Metabolism (2 papers), Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (2 papers), Ferroptosis and cancer prognosis (2 papers), Circadian rhythm and melatonin (2 papers), Effects and risks of endocrine disrupting chemicals (2 papers) and FOXO transcription factor regulation (2 papers). The work is most often cited by research in Aging (33 citations), Reproductive Medicine (68 citations), Cancer Research (57 citations), Public Health, Environmental and Occupational Health (101 citations) and Molecular Biology (172 citations). Feifei Kong has collaborated with scholars based in China. Frequent co-authors include Jing Li, Jing Zhang, Wenwen Liu, Xiaoxu Peng, Xiaowei Dou, Haihua Yuan, Sun Yan, Bin Jiang, Mei Zhao and Jiongyi Wang. Their work appears in journals such as Cell Death and Disease, Autophagy, British Journal of Cancer, Oncology Reports and Journal of Cellular Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.